REPLIGEN CORP — Director's Dealing 2021

Feb 10, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-12-31

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-10	Common Stock	G	1000	$0.00	Disposed	232327	Direct

Footnotes

F1: Represents shares of Common Stock that the reporting person donated as a gift to the Hunt Family Fund, a donor advised fund.